Management of borderline personality disorder: Emerging, new pharmacological and non-pharmacological strategies

Acta Psychiatrica Scandinavica

Volumn 119, Issue 1, 2009, Pages 85-86

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; OLANZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE;

BEHAVIOR THERAPY; BORDERLINE STATE; DRUG EFFICACY; EMOTIONAL DISORDER; HUMAN; LETTER; PRIORITY JOURNAL; RATING SCALE;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BORDERLINE PERSONALITY DISORDER; COMBINED MODALITY THERAPY; HUMANS; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 57449112337     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2008.01290.x     Document Type: Letter

References (13)

1. Reisch T, Ebner-Priemer UW, Tschacher W, Bohus M, Linehan MM. Sequences of emotions in patients with borderline personality disorder. Acta Psychiatr Scand 2008 118 : 42 48.
2. Linehan MM, Mcdavid JD, Brown MZ, Sayrs JH, Gallop RJ. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2008 69 : 999 1005.
3. Friedel RO, Jackson WT, Huston CS, May RS, Kirby NL, Stoves A. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study. J Clin Psychopharmacol 2008 28 : 345.
4. Diaz-Marsa M, Galian M, Montes A et al. Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report. Actas Esp Psiquiatr 2008 36 : 70 74.
5. Peris L, Szerman N, Ruiz M. Efficacy and safety of gabapentin in borderline personality disorder: a six-month, open-label study. Vertex 2007 18 : 418 422.
6. Nickel MK, Loew TH. Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up. Eur Psychiatry 2008 23 : 115 117.
7. Van Den Eynde F, Senturk V, Naudts K et al. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. J Clin Psychopharmacol 2008 28 : 147 155.
8. Mauri MC, Volonteri LS, Fiorentini A, Pirola R, Bareggi SR. Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels. Expert Opin Pharmacother 2007 8 : 2207 2213.
9. Golubchik P, Sever J, Zalsman G, Weizman A. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Int Clin Psychopharmacol 2008 23 : 228 231.
10. Zanarini MC, Frankenburg FR. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Personal Disord 2008 22 : 284 290.
11. Choi-Kain LW, Gunderson JG. Mentalization: ontogeny, assessment, and application in the treatment of borderline personality disorder. Am J Psychiatry 2008 165 : 1127 1135.
12. Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry 2008 165 : 631 638.
13. Van Asselt AD, Dirksen CD, Arntz A et al. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. Br J Psychiatry 2008 192 : 450 457.